NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neumind

Neumind

Private
United KingdomHealthcare & Life Scienceshttps://www.neumind.io/

Last Round

Grant

Jan 1, 2023

Total Funding Raised

$198,000

Company Overview

Neumind is a health technology company that provides a digital neurorehabilitation platform designed to support patients, caregivers, and clinicians with cognitive recovery tools.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

neurorehabilitationdigital healthpatient engagementcognitive supportcare coordinationhealthtechvertical SaaStelemedicineremote patient monitoringRPMclinical workflowtherapy adherenceAI-assisted toolscare cliffbrain injury recovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neumind Comparables

Compare Neumind with similar companies based on industry and business-model similarity.

Neumind comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Constant Therapy Health
82%
Brain in Hand
67%
MindMaze
64%

Neumind Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2023
GrantMay 31, 2022
AcceleratorSep 10, 2021
GrantJan 12, 2021
AcceleratorOct 26, 2020
Accelerator
Sep 19, 2019

Key People

Founding team and executive leadership

Ellis Parry

Co-founder & CEO

Founding Team

Neumind Investors

Notable investors and investment history

Neumind investors
InvestorRounds
EIT HealthAccelerator
Bethnal Green VenturesAccelerator
EPSRCGrant
The King's TrustGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 12, 2021

    $7K grant received from The King's Trust.

  • Oct 26, 2020

    $5K raised from Aspect Student Accelerator Programme.

Neumind Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neumind Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neumind's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited Kingdom
Employee Range3
Year FoundedN/A
Last FundingJan 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.